Why Fountain Only Uses IV Ketamine: The Gold Standard for Safety and Results

Over the past few years, the use of ketamine for mental health treatment has grown rapidly, but not always responsibly. As compounding pharmacies began formulating ketamine in new ways around 2018–2019, a wave of at-home oral and intranasal kits followed. These kits made ketamine more accessible, but they also introduced new risks: uncontrolled dosing, lack of supervision, and no physiological monitoring.

At Fountain Health NYC, we believed from day one that ketamine deserves to be handled with the same rigor as any other medical procedure. It’s not about convenience. It’s about safety, precision, and lasting outcomes.

A Quick Word on Compounded Medications

Compounded medicationsCustom prescriptions made by a pharmacy to fit individual needs. In clinical practice, they're tailored for dose, delivery method, or combined ingredi... are customized formulations prepared by specialized pharmacies to meet a patient’s individual needs. They allow flexibility in dosage forms and strengths, but they’re not FDA-approved in the same way as commercial drugs. When ketamine began to be compounded in oral troches, lozenges, or nasal sprays, it created an opening for telehealthMedical care delivered via phone or video. companies to distribute these directly to patients, often with minimal medical oversight.

While well-intentioned, this shift blurred the line between clinical medicine and self-administration. And for a drug as pharmacologically complex as ketamine, that difference matters.

Why the Route of Administration Matters

Ketamine’s route of administration, how it enters the body, determines how quickly it acts, how much of it is absorbed (bioavailabilityHow much of a medication or nutrient actually reaches the bloodstream and tissues after being taken.), and how predictably it works.

• At-Home Ketamine Kits (Oral and Intranasal)
  Oral ketamine has a bioavailability of roughly 15–25%, and intranasal around 40–50%. Both forms show rapid peaks and sharp declines in blood plasma levels. Meaning the concentration of the drug in the body rises fast, then drops off quickly. Clinically, that translates to shorter, more unstable experiences that are harder to control and less therapeutic.

Imagine an abrupt surge of stimulation followed by a crash: a spike rather than a sustained curve. These fluctuations can trigger anxietyA state of worry or tension that disrupts focus and sleep., dissociationA feeling of disconnection from thoughts, feelings, surroundings, or sense of self., or physical discomfort without the presence of trained clinicians to help regulate the experience.

• IV Ketamine (Intravenous Infusion)
  Intravenous delivery maintains a steady, controlled infusion, creating a smooth rise in blood plasma levels and allowing clinicians to sustain the therapeutic window - the point where neuroplasticity and neuronal growth occur most effectively.
  This steady curve is the foundation of Fountain’s medical model: a stable, measurable, and deeply restorative experience guided by expert oversight.

Read: The First Study To Compare IV ketamine and IN esketamine for depression | The Harvard Gazette

How Fountain Developed Its IV Ketamine Protocol

Before introducing IV ketamine as part of our practice, the Fountain Health traveled across the United States, meeting with leading researchers, anesthesiologists, and psychiatrists who had been studying ketamine since its earliest clinical use. We wanted to understand not only the data, but the experience: what patients felt, how their bodies responded, and what truly drove long-term improvement.

What we found was clear: success lies in the details… in how you select, prepare, and monitor patients.

1. Patient Selection

Every patient at Fountain begins with a 15-minute consultation, followed by a 45-minute psychiatric evaluation and comprehensive lab work.
We analyze over 150 biomarkers, assessing micronutrient levels, inflammation, hormones, metabolic and cardiovascular function, and perform genetic testing, where appropriate.

This understanding of one’s biology allows us to understand how each patient may metabolize the drug and tailor treatment accordingly.

2. Dosing Precision

While most clinics use a standard 0.5 mg/kg formula described by Dr. Huberman, Fountain’s proprietary dosing model goes further that the base standard. We consider variables such as:

• Metabolic rate and liver enzyme function (CYP2B6, CYP3A4)
• Body composition and lean mass ratio
• Cardiovascular status and autonomic tone
• Medication interactions
• Psychological readiness and treatment goals

Our unique dosing algorithm is based on target blood plasma levels, not just body weight. By focusing on the actual concentration of ketamine in the bloodstream, we can precisely guide the intensity and duration of each session.

3. Controlled Infusion and Monitoring

During every infusion:

• Baseline vitals: blood pressure, heart rate, oxygen saturation, and respiratory rate are taken.
• Vital signs are then monitored at regular intervals throughout the session.
• A 1:1 clinician-to-patient ratio is maintained at all times.

This allows real-time dose adjustment and ensures that every moment of the experience is safe, supported, and intentional.

Watch: Ketamine: Benefits and Risks for Depression, PTSD, & Neuroplasticity | Huberman Lab

The Therapeutic Window: Why Stability Matters

When we tested various delivery methods, we observed that oral, intranasal, and intramuscular ketamine caused rapid spikes in plasma concentration, producing a quick rise, brief peak, and sharp decline. The therapeutic window, the optimal zone for neural regeneration, was brief and inconsistent.

By contrast, IV infusions allow us to gradually and predictably reach the therapeutic range, sustaining it long enough for deep neurobiological and psychological work to occur.

Think of it as the difference between a flash of light and a sunrise - one illuminates, the other transforms.

Through our proprietary dosing model, Fountain has also been able to extend this window. By maintaining steady blood plasma levels within the optimal range, we’re able to create more sustainable and longer-lasting change.
This stability means:

• Fewer treatments are needed over time.
• Patients experience longer periods of mood stabilization.
• The risk of relapse and symptom recurrence decreases significantly.

In other words, extending the therapeutic window doesn’t just improve the experience of ketamine therapy, it transforms the outcomes. It allows the brain to remain in a state of neuroplastic readiness longer, reinforcing healthy neural connectionsThe formation of synapses between neurons. and translating into meaningful, measurable improvements in daily life.

Bioavailability and Clinical Oversight

IV ketamine offers 100% bioavailability, meaning the entire dose enters the bloodstream, and none is lost to metabolism before reaching the brain.
In-person administration allows our clinicians to observe how each patient responds physiologically and emotionally, adjusting infusion rates and future doses accordingly.
No other method provides this level of precision or safety.

Fountain’s IV Ketamine Model

Every infusion at Fountain is part of a broader, integrated framework that includes:

• Comprehensive preparation and integration sessions
• Real-time physiological monitoring
• On-site clinical supervision
• Post-treatment reflection and integration therapy

From start to finish, patients are never alone in their process. Their experience is observed, supported, and documented to ensure both safety and sustained results.

To learn more about our proprietary infusion model and clinical process, visit our full article on Fountain’s IV Ketamine Approach.

The Future of Responsible Ketamine Care

At Fountain, we’ve always believed that innovation must go hand in hand with responsibility.

Ketamine is not a wellness trend. It’s a powerful medical treatment that, when delivered correctly, can transform lives. But it demands structure, precision, and human connection.

Our work is guided by a simple philosophy: every treatment should heal, never harm.
That’s why we remain committed to the IV route, in-person care, and a fully integrative model that supports mind, body, and spirit from start to finish.